Search Results - "Simpson, D. M."

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study by HEATON, R. K, CLIFFORD, D. B, RIVERA-MINDT, M, VIGIL, O. R, TAYLOR, M. J, COLLIER, A. C, MARRA, C. M, GELMAN, B. B, MCARTHUR, J. C, MORGELLO, S, SIMPSON, D. M, MCCUTCHAN, J. A, FRANKLIN, D. R, ABRAMSON, I, GAMST, A, FENNEMA-NOTESTINE, C, JERNIGAN, T. L, WONG, J, GRANT, I, WOODS, S. P, AKE, C, VAIDA, F, ELLIS, R. J, LETENDRE, S. L, MARCOTTE, T. D, ATKINSON, J. H

“…This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large,…”
Get full text

Determinants of survival in progressive multifocal leukoencephalopathy by MARZOCCHETTI, A, TOMPKINS, T, CLIFFORD, D. B, GANDHI, R. T, KESARI, S, BERGER, J. R, SIMPSON, D. M, PROSPERI, M, DE LUCA, A, KORALNIK, I. J

“…We sought to characterize the role of immunologic, virologic, and radiologic determinants of survival in patients with progressive multifocal…”
Get full text

Pregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial by SIMPSON, D. M, SCHIFITTO, G, CLIFFORD, D. B, MURPHY, T. K, DURSO-DE CRUZ, E, GLUE, P, WHALEN, E, EMIR, B, SCOTT, G. N, FREEMAN, R

“…Pregabalin is effective in several neuropathic pain syndromes. This trial evaluated its efficacy, safety, and tolerability for treatment of painful…”
Get full text

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review) : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by SIMPSON, D. M, GRACIES, J.-M, GRAHAM, H. K, MIYASAKI, J. M, NAUMANN, M, RUSSMAN, B, SIMPSON, L. L, SO, Y

“…To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity. A literature…”
Get full text

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by SIMPSON, D. M, BLITZER, A, NAUMANN, M, SO, Y, BRASHEAR, A, COMELLA, C, DUBINSKY, R, HALLETT, M, JANKOVIC, J, KARP, B, LUDLOW, C. L, MIYASAKI, J. M

“…To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of movement disorders. A literature search was…”
Get full text

Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings by Blackstone, K., Moore, D. J., Franklin, D. R., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Ellis, R. J., Atkinson, J. H., Grant, I., Heaton, R. K.

“…Because HIV-related neurocognitive impairment is usually mild and variable, clinical ratings (CR) and global deficit scores (GDS) are recommended for detecting…”
Get full text

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by NAUMANN, M, SO, Y, SIMPSON, D. M, ARGOFF, C. E, CHILDERS, M. K, DYKSTRA, D. D, GRONSETH, G. S, JABBARI, B, KAUFMANN, H. C, SCHURCH, B, SILBERSTEIN, S. D

“…To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of autonomic and urologic disorders and low back…”
Get full text

Elastase levels and activity are increased in dystrophic muscle and impair myoblast cell survival, proliferation and differentiation by Arecco, N., Clarke, C. J., Jones, F. K., Simpson, D. M., Mason, D., Beynon, R. J., Pisconti, A.

“…In Duchenne muscular dystrophy, progressive loss of muscle tissue is accompanied by fibrosis, chronic inflammation and reduced muscle regenerative capacity…”
Get full text

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy by BIRBECK, G. L, FRENCH, J. A, PERUCCA, E, SIMPSON, D. M, FRAIMOW, H, GEORGE, J. M, OKULICZ, J. F, CLIFFORD, D. B, HACHAD, H, LEVY, R. H

“…To develop guidelines for selection of antiepileptic drugs (AEDs) among people with HIV/AIDS. The literature was systematically reviewed to assess the global…”
Get full text

Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy by POLYDEFKIS, M, YIANNOUTSOS, C. T, BROWN, A, HAIDICH, A. B, MOO, L, MCARTHUR, J. C, COHEN, B. A, HOLLANDER, H, SCHIFITTO, G, CLIFFORD, D. B, SIMPSON, D. M, KATZENSTEIN, D, SHRIVER, S, HAUER, P

“…To explore the relationship between intraepidermal nerve fiber (IENF) density in HIV-associated sensory neuropathy (HIV-SN) to measurements of neuropathy…”
Get full text

Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial by SIMPSON, D. M, MCARTHUR, J. C, OLNEY, R, CLIFFORD, D, SO, Y, ROSS, D, BAIRD, B. J, BARRETT, P, HAMMER, A. E

“…To evaluate the efficacy and tolerability of lamotrigine (LTG) for the treatment of pain in HIV-associated sensory neuropathies. In a randomized, double-blind…”
Get full text

HIV neuropathy natural history cohort study : Assessment measures and risk factors by SIMPSON, D. M, KITCH, D, DIAZ-ARRASTIA, R, SHRIVER, S, MILLAR, L, CLIFFORD, D. B, EVANS, S. R, MCARTHUR, J. C, ASMUTH, D. M, COHEN, B, GOODKIN, K, GERSCHENSON, M, SO, Y, MARRA, C. M

“…Distal sensory polyneuropathy (DSP) is the most common neurologic complication of human immunodeficiency virus (HIV) infection. Risk factors for DSP have not…”
Get full text

Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin by Goswami, S, Yee, S W, Stocker, S, Mosley, J D, Kubo, M, Castro, R, Mefford, J A, Wen, C, Liang, X, Witte, J, Brett, C, Maeda, S, Simpson, M D, Hedderson, M M, Davis, R L, Roden, D M, Giacomini, K M, Savic, R M

“…One‐third of type 2 diabetes patients do not respond to metformin. Genetic variants in metformin transporters have been extensively studied as a likely…”
Get full text

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy by Robinson-Papp, J., Morgello, S., Vaida, F., Fitzsimons, C., Simpson, D.M., Elliott, K.J., Al-Lozi, M., Gelman, B.B., Clifford, D., Marra, C.M., McCutchan, J.A., Atkinson, J.H., Dworkin, R.H., Grant, I., Ellis, R.

“…Sensory neuropathy (HIV-SN) is a common cause of pain in HIV-infected people. Establishing a diagnosis of HIV-SN is important, especially when contemplating…”
Get full text

Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy by ZHOU, L, KITCH, D. W, GOODKIN, K, MILLAR, L, SHRIVER, S, ASMUTH, D. M, CLIFFORD, D. B, SIMPSON, D. M, MCARTHUR, J. C, EVANS, S. R, HAUER, P, RAMAN, S, EBENEZER, G. J, GERSCHENSON, M, MARRA, C. M, VALCOUR, V, DIAZ-ARRASTIA, R

“…To demonstrate the relationship between epidermal nerve fiber density (ENFD) in the leg and the phenotype of HIV-associated distal sensory polyneuropathy…”
Get full text

Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study by Simpson, D M, Gracies, J M, Yablon, S A, Barbano, R, Brashear, A

“…Background:While spasticity is commonly treated with oral agents or botulinum neurotoxin (BoNT) injection, these treatments have not been systematically…”
Get full text

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy by Simpson, D M, Olney, R, McArthur, J C, Khan, A, Godbold, J, Ebel-Frommer, K

“…To investigate the analgesic efficacy of lamotrigine in the treatment of painful HIV-associated distal sensory polyneuropathy (DSP). The pathogenesis of…”
Get full text

Aryloxyalkanoate Dioxygenase-12 Soybean Protein Expression by Robinson, Andrew P., Simpson, D. M., Yau, Kerrm, Canada, Sarah, Johnson, William G.

“…New trait technology incorporating 2,4-D resistance in soybean is dependent upon the ability of the plant to metabolize 2,4-D by the aryloxyalkanoate…”
Get full text

Neuropathic pain needs systematic classification by Finnerup, N.B., Scholz, J., Attal, N., Baron, R., Haanpää, M., Hansson, P., Raja, S.N., Rice, A.S.C., Rief, W., Rowbotham, M.C., Simpson, D.M., Treede, R.-D.

Get full text

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection by MCARTHUR, J. C, YIANNOUTSOS, C, NAVIA, B. A, SCHIFITTO, G, KATZENSTEIN, D, RASK, C, ZABORSKI, L, SMITH, M. E, SHRIVER, S, MILLAR, L, CLIFFORD, D. B, SIMPSON, D. M, ADORNATO, B. T, SINGER, E. J, HOLLANDER, H, MARRA, C, RUBIN, M, COHEN, B. A, TUCKER, T

Get full text